Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer
- PMID: 34064918
- PMCID: PMC8151048
- DOI: 10.3390/jpm11050398
Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer
Abstract
Standard treatment for locally advanced cervical cancer (LACC) is chemoradiotherapy followed by brachytherapy. Despite radiation therapy advances, the toxicity rate remains significant. In this study, we compared the prediction of toxicity events after radiotherapy for locally advanced cervical cancer (LACC), based on either dose-volume histogram (DVH) parameters or the use of a radiomics approach applied to dose maps at the voxel level. Toxicity scores using the Common Terminology Criteria for Adverse Events (CTCAE v4), spatial dose distributions, and usual clinical predictors for the toxicity of 102 patients treated with chemoradiotherapy followed by brachytherapy for LACC were used in this study. In addition to usual DVH parameters, 91 radiomic features were extracted from rectum, bladder and vaginal 3D dose distributions, after discretization into a fixed bin width of 1 Gy. They were evaluated for predictive modelling of rectal, genitourinary (GU) and vaginal toxicities (grade ≥ 2). Logistic Normal Tissue Complication Probability (NTCP) models were derived using clinical parameters only or combinations of clinical, DVH and radiomics. For rectal acute/late toxicities, the area under the curve (AUC) using clinical parameters was 0.53/0.65, which increased to 0.66/0.63, and 0.76/0.87, with the addition of DVH or radiomics parameters, respectively. For GU acute/late toxicities, the AUC increased from 0.55/0.56 (clinical only) to 0.84/0.90 (+DVH) and 0.83/0.96 (clinical + DVH + radiomics). For vaginal acute/late toxicities, the AUC increased from 0.51/0.57 (clinical only) to 0.58/0.72 (+DVH) and 0.82/0.89 (clinical + DVH + radiomics). The predictive performance of NTCP models based on radiomics features was higher than the commonly used clinical and DVH parameters. Dosimetric radiomics analysis is a promising tool for NTCP modelling in radiotherapy.
Keywords: NTCP; cervical cancer; radiomics; radiotherapy; toxicity.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapy.Radiother Oncol. 2018 Dec;129(3):548-553. doi: 10.1016/j.radonc.2018.07.027. Epub 2018 Aug 31. Radiother Oncol. 2018. PMID: 30177372
-
Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer.Radiother Oncol. 2021 Feb;155:144-150. doi: 10.1016/j.radonc.2020.10.040. Epub 2020 Nov 6. Radiother Oncol. 2021. PMID: 33161012
-
Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose.Front Oncol. 2022 Dec 16;12:1084311. doi: 10.3389/fonc.2022.1084311. eCollection 2022. Front Oncol. 2022. PMID: 36591496 Free PMC article.
-
Delta-radiomics-based models for toxicity prediction in radiotherapy: A systematic review and meta-analysis.J Med Imaging Radiat Oncol. 2023 Aug;67(5):564-579. doi: 10.1111/1754-9485.13546. Epub 2023 Jun 13. J Med Imaging Radiat Oncol. 2023. PMID: 37309680
-
The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review.Cancers (Basel). 2022 Dec 19;14(24):6252. doi: 10.3390/cancers14246252. Cancers (Basel). 2022. PMID: 36551737 Free PMC article. Review.
Cited by
-
Prediction of Radiation-Induced Hypothyroidism Using Radiomic Data Analysis Does Not Show Superiority over Standard Normal Tissue Complication Models.Cancers (Basel). 2021 Nov 8;13(21):5584. doi: 10.3390/cancers13215584. Cancers (Basel). 2021. PMID: 34771747 Free PMC article.
-
Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy.PLoS One. 2025 May 14;20(5):e0312208. doi: 10.1371/journal.pone.0312208. eCollection 2025. PLoS One. 2025. PMID: 40367095 Free PMC article.
-
Association of Multi-Phasic MR-Based Radiomic and Dosimetric Features with Treatment Response in Unresectable Hepatocellular Carcinoma Patients following Novel Sequential TACE-SBRT-Immunotherapy.Cancers (Basel). 2023 Feb 9;15(4):1105. doi: 10.3390/cancers15041105. Cancers (Basel). 2023. PMID: 36831445 Free PMC article.
-
Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: A study by the Italian association of radiotherapy and clinical oncology (AIRO).Clin Transl Radiat Oncol. 2023 Oct 6;43:100688. doi: 10.1016/j.ctro.2023.100688. eCollection 2023 Nov. Clin Transl Radiat Oncol. 2023. PMID: 37854671 Free PMC article.
-
A prediction method for radiation proctitis based on SAM-Med2D model.Sci Rep. 2025 Apr 18;15(1):13426. doi: 10.1038/s41598-025-87409-6. Sci Rep. 2025. PMID: 40251184 Free PMC article.
References
-
- Sun L.-M., Huang E.-Y., Ko S.-F., Wang C.-J., Leung S.W., Lin H., Wu J.-M., Wu I.-H., Lee S.P. Computer tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer. Radiother. Oncol. 2004;71:333–337. doi: 10.1016/j.radonc.2004.03.001. - DOI - PubMed
LinkOut - more resources
Full Text Sources